Koyfin Home > Directory > Health Care > Iradimed Cp > EV / EBITDA (ntm)

Iradimed Cp EV / EBITDA (ntm) Chart (IRMD)

Iradimed Cp annual/quarterly EV / EBITDA (ntm) from 2014 to 2019. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Iradimed Cp EV / EBITDA (ntm) for the quarter ending February 02, 2019 was 20.85 a -11.45% decrease of -2.39 year over year
  • Iradimed Cp EV / EBITDA (ntm) for the last 12 months ending February 02, 2019 was 20.85 a -11.45% decrease of -2.39 year over year
  • Iradimed Cp Annual EV / EBITDA (ntm) for 2019 was 20.85 a -12.90% decrease of -2.69 from 2018
  • Iradimed Cp Annual EV / EBITDA (ntm) for 2019 was 23.54 a 1.40% increase of 0.33 from 2018
  • Iradimed Cp Annual EV / EBITDA (ntm) for 2019 was 23.21 a -0.12% decrease of -0.03 from 2018
Other Valuation Metrics:
  • Iradimed Cp Market Cap for the quarter ending March 03, 2018 was $153m a 39.46% increase of 60m year over year
  • Iradimed Cp Price / Book for the quarter ending March 03, 2018 was 4.63 a 37.70% increase of 1.75 year over year
  • Iradimed Cp Enterprise Value for the quarter ending March 03, 2018 was $126m a 46.82% increase of 59m year over year
View Chart On Koyfin

Quarterly IRMD EV / EBITDA (ntm) Data

02/201920.85
02/201923.54
02/201923.21
02/201923.24
01/201923.16
01/201922.44
01/201921.98
01/201921.67
01/201921.59
01/201920.72

Annual IRMD EV / EBITDA (ntm) Data

201920.85
201923.54
201923.21
201923.24
201923.16
201922.44
201921.98
201921.67
201921.59
201920.72